Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium.
AMR
Mycoplasma genitalium
antimicrobial resistance
doxycycline
dual-class resistance
macrolide resistance
multidrug resistance
quinolone resistance
sexually transmitted infections
sitafloxacin
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
21
7
2020
pubmed:
21
7
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
Antimicrobial-resistant Mycoplasma genitalium is becoming increasingly common and creating major treatment challenges. We present early data on combination therapy with doxycycline and sitafloxacin to treat highly resistant M. genitalium. We found the regimen was well tolerated and cured 11/12 infections that had failed prior regimens with moxifloxacin and pristinamycin.
Identifiants
pubmed: 32687029
doi: 10.3201/eid2608.191806
pmc: PMC7392426
doi:
Substances chimiques
Anti-Bacterial Agents
0
Fluoroquinolones
0
Macrolides
0
sitafloxacin
9TD681796G
Doxycycline
N12000U13O
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1870-1874Références
Clin Infect Dis. 2019 Oct 20;:
pubmed: 31629365
PLoS One. 2018 Jun 8;13(6):e0198355
pubmed: 29883482
Sex Transm Dis. 2019 Jan;46(1):18-24
pubmed: 29979336
Emerg Infect Dis. 2018 Feb;24(2):328-335
pubmed: 29350154
Clin Infect Dis. 2019 Feb 1;68(4):554-560
pubmed: 29873691
Int J STD AIDS. 2019 Sep;30(10):938-950
pubmed: 31280688
J Infect Dis. 2020 Mar 2;221(6):1017-1024
pubmed: 32031634
Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1565-1567
pubmed: 28361246
J Infect Dis. 2017 Jul 15;216(suppl_2):S412-S419
pubmed: 28838073
J Infect Chemother. 2013 Oct;19(5):941-5
pubmed: 23749142